Clinical and pharmacological group: & nbsp

Means for enteral and parenteral nutrition

Included in the formulation
АТХ:

V.06.D.X   Other combined preparations for nutrition

Pharmacodynamics:

Participates in anabolic processes, accelerates the repair process, slows catabolic processes, is part of the buffer system that regulates homeostasis.

Pharmacokinetics:After intravenous administration, it is mostly used for protein synthesis. The remaining 5% are deaminated in the liver before urea formation. Elimination by the kidneys.
Indications:Used for parenteral nutrition, replenishment of fluid loss, for the prevention and treatment of protein deficiency of various genesis (with burns, surgeries, blood loss, etc.).

IV.E40-E46.E46   Protein-energy insufficiency, unspecified

Contraindications:

Acute period of craniocerebral trauma, unstable blood circulation with life threat (shock), hyperhydration, renal failure in the stage of decompensation, hepatic insufficiency in the stage of decompensation, disorders of amino acid metabolism, methanol intoxication, anuria, pulmonary edema, lactic acidosis, hyperkalemia.

Carefully:Heart failure at the stage of decompensation.
Pregnancy and lactation:

Recommendations for FDA - Category B. The drug is used in pregnancy and lactation according to indications.

Dosing and Administration:

Introduced intravenously drip slowly. 0.6-1.0 g / kg per day.

The highest daily dose: 2.0 g.

The highest single dose: 1.0 g.

Side effects:

Allergic reactions.

Overdose:

Tachycardia, chills, hyperhidrosis - at a high rate of administration.

Interaction:

Clinically significant interactions are not described.

Special instructions:

Monitoring of acid-base balance, water-electrolyte balance. In patients with renal and hepatic insufficiency, adequate diuresis should be achieved before using the drug.

Do not mix the drug with other medicines.

Instructions
Up